First Trust NYSE Arca Biotechnology Index Fund (FBT) |
| 262.28 -3.283 (-1.24%) 09-10 16:00 |
| Open: | 262.455 |
| High: | 264.52 |
| Low: | 261.82 |
| Volume: | 53,558 |
| Market Cap: | 1,633(M) |
| PE Ratio: | 28.66 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 321.19 |
| Resistance 1: | 274.99 |
| Pivot price: | 269.34 |
| Support 1: | 257.53 |
| Support 2: | 246.74 |
| 52w High: | 274.99 |
| 52w Low: | 173.98 |
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 10 Sep 2026
Trading the Move, Not the Narrative: (FBT) Edition - news.stocktradersdaily.com
Thu, 10 Sep 2026
Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT? - The Motley Fool
Thu, 10 Sep 2026
Which Is the Better Healthcare ETF: Fidelity's Low-Cost FHLC or First Trust's High-Conviction FBT? - The Globe and Mail
Tue, 01 Sep 2026
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Wed, 19 Aug 2026
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets? - The Motley Fool
Thu, 13 Aug 2026
IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play? - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
